KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Non-Current Debt (2016 - 2025)

Tenet Healthcare's Non-Current Debt history spans 17 years, with the latest figure at $13.1 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt changed 0.08% year-over-year to $13.1 billion; the TTM value through Dec 2025 reached $13.1 billion, changed 0.08%, while the annual FY2025 figure was $13.1 billion, 0.08% changed from the prior year.
  • Non-Current Debt for Q4 2025 was $13.1 billion at Tenet Healthcare, roughly flat from $13.1 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $15.5 billion in Q4 2021 and bottomed at $12.8 billion in Q2 2024.
  • The 5-year median for Non-Current Debt is $14.8 billion (2022), against an average of $14.1 billion.
  • The largest annual shift saw Non-Current Debt rose 6.8% in 2022 before it fell 14.48% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $15.5 billion in 2021, then dropped by 3.72% to $14.9 billion in 2022, then fell by 0.35% to $14.9 billion in 2023, then decreased by 12.1% to $13.1 billion in 2024, then grew by 0.08% to $13.1 billion in 2025.
  • Per Business Quant, the three most recent readings for THC's Non-Current Debt are $13.1 billion (Q4 2025), $13.1 billion (Q3 2025), and $13.1 billion (Q2 2025).